Gates Foundation Strategic Investment Fund Logo
Share this page:

Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

[September 8, 2021] Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, today announced a four-year collaboration with the Bill & Melinda Gates Foundation, a non-profit focused on fighting global poverty, disease, and inequity, to develop small molecule therapeutics that tackle the current Coronavirus pandemic and help prepare for future pandemics.


Read the full Press Release here.